Publications by authors named "N C Zeitouni"

Article Synopsis
  • Dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue cancer known for its aggressive growth and high chance of returning after treatment.
  • The study reviews nine imaging techniques like Ultrasound (US) and MRI, highlighting their roles primarily in preoperative assessment and planning rather than diagnosis.
  • Key findings suggest US and MRI are most effective for evaluating DFSP, while emerging technologies like MRS and OCT may enhance accuracy in future management, warranting further research to improve patient outcomes.
View Article and Find Full Text PDF

Background: Access to dermatologists is limited in parts of the US, making primary care clinicians (PCCs) integral for early detection of skin cancers. A handheld device using elastic scattering spectroscopy (ESS) was developed to aid PCCs in their clinical assessment of skin lesions.

Methods: In this prospective study, 3 PCCs evaluated skin lesions reported by patients as concerning and scanned each lesion with the handheld ESS device.

View Article and Find Full Text PDF

Melanoma, accounting for a significant proportion of skin cancer-related deaths, has variable survival outcomes based on the stage at diagnosis and treatment efficacy. Traditional treatments, while effective, pose risks of scarring and systemic side effects. Laser therapy offers an emerging non-surgical alternative, with CO2 lasers particularly showing promise in palliative care.

View Article and Find Full Text PDF

Background: Clinical magnetic resonance imaging (MRI) studies often use Cartesian gradient-echo (GRE) sequences with ~2-ms echo times (TEs) to monitor apparent total sodium concentration (aTSC). We compared Cartesian GRE and ultra-short echo time three-dimensional (3D) radial-readout sequences for measuring skeletal muscle aTSC.

Methods: We retrospectively evaluated 211 datasets from 112 volunteers aged 62.

View Article and Find Full Text PDF

Treatment responses for locally advanced cutaneous squamous cell carcinoma (cSCC) and Merkel cell carcinoma (MCC) are often short lived and are marred with recurrences. The introduction of adjuvant PD-1 inhibitors has demonstrated significant improvement in both, response rates, and duration of response. For patients with high-risk resectable disease, adjuvant treatments have not demonstrated an ability to reduce recurrence risk.

View Article and Find Full Text PDF